 | • レポートコード：GIR-2104Z06366 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子工学用医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子工学用医薬品の種類別市場規模（モノクローナル抗体、組換えヒトエリスロポエチン、組換えヒトインターフェロン、組換えヒト成長ホルモン、組換えヒトインスリン）、用途別市場規模（医療、研究、工業、農業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子工学用医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Shanghai Lansheng Guojian Pharmaceutical、Biotech Pharmaceutical、Anhui Anke Biotechnology、GeneScience Pharmaceuticals、Beijing SL Pharmaceutical、Jiangsu Sihuan Bioengineering、Shenzhen Neptunus Interlong Bio-Technique、3SBio、Tonghua Dongbao Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、組換えヒトエリスロポエチン、組換えヒトインターフェロン、組換えヒト成長ホルモン、組換えヒトインスリン ・用途別分析2016年-2026年：医療、研究、工業、農業、その他 ・遺伝子工学用医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子工学用医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子工学用医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子工学用医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子工学用医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Genetic Engineering Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Genetic Engineering Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Genetic Engineering Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Genetic Engineering Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
Market segment by Application can be divided into
Medicine
Research
Industrial
Agriculture
Other
The key market players for global Genetic Engineering Drug market are listed below:
Shanghai Lansheng Guojian Pharmaceutical
Biotech Pharmaceutical
Anhui Anke Biotechnology
GeneScience Pharmaceuticals
Beijing SL Pharmaceutical
Jiangsu Sihuan Bioengineering
Shenzhen Neptunus Interlong Bio-Technique
3SBio
Tonghua Dongbao Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Genetic Engineering Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Genetic Engineering Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Market Analysis by Application
1.3.1 Overview: Global Genetic Engineering Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Medicine
1.3.3 Research
1.3.4 Industrial
1.3.5 Agriculture
1.3.6 Other
1.4 Global Genetic Engineering Drug Market Size & Forecast
1.4.1 Global Genetic Engineering Drug Sales in Value (2016-2026))
1.4.2 Global Genetic Engineering Drug Sales in Volume (2016-2026)
1.4.3 Global Genetic Engineering Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Genetic Engineering Drug Production Capacity Analysis
1.5.1 Global Genetic Engineering Drug Total Production Capacity (2016-2026)
1.5.2 Global Genetic Engineering Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Engineering Drug Market Drivers
1.6.2 Genetic Engineering Drug Market Restraints
1.6.3 Genetic Engineering Drug Trends Analysis
2 Manufacturers Profiles
2.1 Shanghai Lansheng Guojian Pharmaceutical
2.1.1 Shanghai Lansheng Guojian Pharmaceutical Details
2.1.2 Shanghai Lansheng Guojian Pharmaceutical Major Business
2.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
2.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Biotech Pharmaceutical
2.2.1 Biotech Pharmaceutical Details
2.2.2 Biotech Pharmaceutical Major Business
2.2.3 Biotech Pharmaceutical Genetic Engineering Drug Product and Services
2.2.4 Biotech Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Anhui Anke Biotechnology
2.3.1 Anhui Anke Biotechnology Details
2.3.2 Anhui Anke Biotechnology Major Business
2.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
2.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 GeneScience Pharmaceuticals
2.4.1 GeneScience Pharmaceuticals Details
2.4.2 GeneScience Pharmaceuticals Major Business
2.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
2.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Beijing SL Pharmaceutical
2.5.1 Beijing SL Pharmaceutical Details
2.5.2 Beijing SL Pharmaceutical Major Business
2.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
2.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Jiangsu Sihuan Bioengineering
2.6.1 Jiangsu Sihuan Bioengineering Details
2.6.2 Jiangsu Sihuan Bioengineering Major Business
2.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
2.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Shenzhen Neptunus Interlong Bio-Technique
2.7.1 Shenzhen Neptunus Interlong Bio-Technique Details
2.7.2 Shenzhen Neptunus Interlong Bio-Technique Major Business
2.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
2.7.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 3SBio
2.8.1 3SBio Details
2.8.2 3SBio Major Business
2.8.3 3SBio Genetic Engineering Drug Product and Services
2.8.4 3SBio Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Tonghua Dongbao Pharmaceutical
2.9.1 Tonghua Dongbao Pharmaceutical Details
2.9.2 Tonghua Dongbao Pharmaceutical Major Business
2.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
2.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Genetic Engineering Drug Sales by Manufacturer
3.1 Global Genetic Engineering Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Genetic Engineering Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Genetic Engineering Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Genetic Engineering Drug Manufacturer Market Share
3.4.2 Top 6 Genetic Engineering Drug Manufacturer Market Share
3.5 Global Genetic Engineering Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Genetic Engineering Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Genetic Engineering Drug Market Size by Region
4.1.1 Global Genetic Engineering Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Genetic Engineering Drug Revenue by Region (2016-2026)
4.2 North America Genetic Engineering Drug Revenue (2016-2026)
4.3 Europe Genetic Engineering Drug Revenue (2016-2026)
4.4 Asia-Pacific Genetic Engineering Drug Revenue (2016-2026)
4.5 South America Genetic Engineering Drug Revenue (2016-2026)
4.6 Middle East and Africa Genetic Engineering Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Genetic Engineering Drug Sales in Volume by Type (2016-2026)
5.2 Global Genetic Engineering Drug Revenue by Type (2016-2026)
5.3 Global Genetic Engineering Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Genetic Engineering Drug Sales in Volume by Application (2016-2026)
6.2 Global Genetic Engineering Drug Revenue by Application (2016-2026)
6.3 Global Genetic Engineering Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Genetic Engineering Drug Sales by Type (2016-2026)
7.2 North America Genetic Engineering Drug Sales by Application (2016-2026)
7.3 North America Genetic Engineering Drug Market Size by Country
7.3.1 North America Genetic Engineering Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Genetic Engineering Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Genetic Engineering Drug Sales by Type (2016-2026)
8.2 Europe Genetic Engineering Drug Sales by Application (2016-2026)
8.3 Europe Genetic Engineering Drug Market Size by Country
8.3.1 Europe Genetic Engineering Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Genetic Engineering Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Genetic Engineering Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Genetic Engineering Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Genetic Engineering Drug Market Size by Region
9.3.1 Asia-Pacific Genetic Engineering Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Genetic Engineering Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Genetic Engineering Drug Sales by Type (2016-2026)
10.2 South America Genetic Engineering Drug Sales by Application (2016-2026)
10.3 South America Genetic Engineering Drug Market Size by Country
10.3.1 South America Genetic Engineering Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Genetic Engineering Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Genetic Engineering Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Genetic Engineering Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Genetic Engineering Drug Market Size by Country
11.3.1 Middle East & Africa Genetic Engineering Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Genetic Engineering Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Genetic Engineering Drug Typical Distributors
12.3 Genetic Engineering Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Genetic Engineering Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Genetic Engineering Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Shanghai Lansheng Guojian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shanghai Lansheng Guojian Pharmaceutical Major Business
Table 5. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product and Services
Table 6. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biotech Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Biotech Pharmaceutical Major Business
Table 9. Biotech Pharmaceutical Genetic Engineering Drug Product and Services
Table 10. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Anhui Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 12. Anhui Anke Biotechnology Major Business
Table 13. Anhui Anke Biotechnology Genetic Engineering Drug Product and Services
Table 14. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GeneScience Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. GeneScience Pharmaceuticals Major Business
Table 17. GeneScience Pharmaceuticals Genetic Engineering Drug Product and Services
Table 18. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Beijing SL Pharmaceutical Major Business
Table 21. Beijing SL Pharmaceutical Genetic Engineering Drug Product and Services
Table 22. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Jiangsu Sihuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 24. Jiangsu Sihuan Bioengineering Major Business
Table 25. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product and Services
Table 26. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Shenzhen Neptunus Interlong Bio-Technique Basic Information, Manufacturing Base and Competitors
Table 28. Shenzhen Neptunus Interlong Bio-Technique Major Business
Table 29. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product and Services
Table 30. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. 3SBio Basic Information, Manufacturing Base and Competitors
Table 32. 3SBio Major Business
Table 33. 3SBio Genetic Engineering Drug Product and Services
Table 34. 3SBio Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Tonghua Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Tonghua Dongbao Pharmaceutical Major Business
Table 37. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product and Services
Table 38. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Genetic Engineering Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Genetic Engineering Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Genetic Engineering Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Genetic Engineering Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Genetic Engineering Drug Production Site of Key Manufacturer
Table 44. Global Genetic Engineering Drug Sales by Region (2016-2021e) & (K Units)
Table 45. Global Genetic Engineering Drug Sales by Region (2021-2026) & (K Units)
Table 46. Global Genetic Engineering Drug Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Genetic Engineering Drug Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Genetic Engineering Drug Sales by Type (2016-2021e) & (K Units)
Table 49. Global Genetic Engineering Drug Sales by Type (2021-2026) & (K Units)
Table 50. Global Genetic Engineering Drug Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Genetic Engineering Drug Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Genetic Engineering Drug Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Genetic Engineering Drug Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Genetic Engineering Drug Sales by Application (2016-2021e) & (K Units)
Table 55. Global Genetic Engineering Drug Sales by Application (2021-2026) & (K Units)
Table 56. Global Genetic Engineering Drug Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Genetic Engineering Drug Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Genetic Engineering Drug Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Genetic Engineering Drug Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Genetic Engineering Drug Sales by Country (2016-2021e) & (K Units)
Table 61. North America Genetic Engineering Drug Sales by Country (2021-2026) & (K Units)
Table 62. North America Genetic Engineering Drug Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Genetic Engineering Drug Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Genetic Engineering Drug Sales by Type (2016-2021e) & (K Units)
Table 65. North America Genetic Engineering Drug Sales by Type (2021-2026) & (K Units)
Table 66. North America Genetic Engineering Drug Sales by Application (2016-2021e) & (K Units)
Table 67. North America Genetic Engineering Drug Sales by Application (2021-2026) & (K Units)
Table 68. Europe Genetic Engineering Drug Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Genetic Engineering Drug Sales by Country (2021-2026) & (K Units)
Table 70. Europe Genetic Engineering Drug Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Genetic Engineering Drug Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Genetic Engineering Drug Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Genetic Engineering Drug Sales by Type (2021-2026) & (K Units)
Table 74. Europe Genetic Engineering Drug Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Genetic Engineering Drug Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Genetic Engineering Drug Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Genetic Engineering Drug Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Genetic Engineering Drug Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Genetic Engineering Drug Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Genetic Engineering Drug Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Genetic Engineering Drug Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Genetic Engineering Drug Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Genetic Engineering Drug Sales by Application (2021-2026) & (K Units)
Table 84. South America Genetic Engineering Drug Sales by Country (2016-2021e) & (K Units)
Table 85. South America Genetic Engineering Drug Sales by Country (2021-2026) & (K Units)
Table 86. South America Genetic Engineering Drug Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Genetic Engineering Drug Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Genetic Engineering Drug Sales by Type (2016-2021e) & (K Units)
Table 89. South America Genetic Engineering Drug Sales by Type (2021-2026) & (K Units)
Table 90. South America Genetic Engineering Drug Sales by Application (2016-2021e) & (K Units)
Table 91. South America Genetic Engineering Drug Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Genetic Engineering Drug Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Genetic Engineering Drug Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Genetic Engineering Drug Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Genetic Engineering Drug Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Genetic Engineering Drug Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Genetic Engineering Drug Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Genetic Engineering Drug Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Genetic Engineering Drug Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Genetic Engineering Drug Typical Distributors
Table 103. Genetic Engineering Drug Typical Customers
List of Figures
Figure 1. Genetic Engineering Drug Picture
Figure 2. Global Genetic Engineering Drug Sales Market Share by Type in 2020
Figure 3. Monoclonal Antibody
Figure 4. Recombinant Human Erythropoietin
Figure 5. Recombinant Human Interferon
Figure 6. Recombinant Human Growth Hormone
Figure 7. Recombinant Human Insulin
Figure 8. Global Genetic Engineering Drug Sales Market Share by Application in 2020
Figure 9. Medicine
Figure 10. Research
Figure 11. Industrial
Figure 12. Agriculture
Figure 13. Other
Figure 14. Global Genetic Engineering Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Genetic Engineering Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Genetic Engineering Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Genetic Engineering Drug Sales (2016-2026) & (K Units)
Figure 36. Global Genetic Engineering Drug Production Capacity (2016-2026) & (K Units)
Figure 37. Global Genetic Engineering Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Genetic Engineering Drug Market Drivers
Figure 39. Genetic Engineering Drug Market Restraints
Figure 40. Genetic Engineering Drug Market Trends
Figure 41. Global Genetic Engineering Drug Sales Market Share by Manufacturer in 2020
Figure 42. Global Genetic Engineering Drug Revenue Market Share by Manufacturer in 2020
Figure 43. Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Genetic Engineering Drug Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Genetic Engineering Drug Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Genetic Engineering Drug Sales Market Share by Region (2016-2026)
Figure 47. Global Genetic Engineering Drug Revenue Market Share by Region (2016-2026)
Figure 48. North America Genetic Engineering Drug Revenue (2016-2026) & (USD Million)
Figure 49. Europe Genetic Engineering Drug Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Genetic Engineering Drug Revenue (2016-2026) & (USD Million)
Figure 51. South America Genetic Engineering Drug Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Genetic Engineering Drug Revenue (2016-2026) & (USD Million)
Figure 53. Global Genetic Engineering Drug Sales Market Share by Type (2016-2026)
Figure 54. Global Genetic Engineering Drug Revenue Market Share by Type (2016-2026)
Figure 55. Global Genetic Engineering Drug Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Genetic Engineering Drug Sales Market Share by Application (2016-2026)
Figure 57. Global Genetic Engineering Drug Revenue Market Share by Application (2016-2026)
Figure 58. Global Genetic Engineering Drug Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Genetic Engineering Drug Sales Market Share by Country (2016-2026)
Figure 60. North America Genetic Engineering Drug Revenue Market Share by Country (2016-2026)
Figure 61. North America Genetic Engineering Drug Sales Market Share by Type (2016-2026)
Figure 62. North America Genetic Engineering Drug Sales Market Share by Application (2016-2026)
Figure 63. Europe Genetic Engineering Drug Sales Market Share by Country (2016-2026)
Figure 64. Europe Genetic Engineering Drug Revenue Market Share by Country (2016-2026)
Figure 65. Europe Genetic Engineering Drug Sales Market Share by Type (2016-2026)
Figure 66. Europe Genetic Engineering Drug Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Genetic Engineering Drug Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Genetic Engineering Drug Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Genetic Engineering Drug Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Genetic Engineering Drug Sales Market Share by Application (2016-2026)
Figure 71. South America Genetic Engineering Drug Sales Market Share by Country (2016-2026)
Figure 72. South America Genetic Engineering Drug Revenue Market Share by Country (2016-2026)
Figure 73. South America Genetic Engineering Drug Sales Market Share by Type (2016-2026)
Figure 74. South America Genetic Engineering Drug Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Genetic Engineering Drug Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Genetic Engineering Drug Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の組換え抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant Antibody Market The global Recombinant Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…- 世界の組換えワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の新型コロナウイルス感染症組換えタンパク質ワクチン市場規模・現状・予測（2021年-2027年） Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-ol…
- 世界の血友病A・B組換え因子補充療法市場規模・現状・予測（2021年-2027年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 世界の組換えDNA技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recombinant DNA Technology Market The global Recombinant DNA Technology market size is projected to reach US$ 644 million by 2026, from US$ 490.8 million in 2019, at a CAGR of 3.9% during 2021-2026. With industry-standard accuracy in analysis and high data integr…